BridgeBio Oncology Therapeutics
Developing small molecule therapeutics targeting RAS and PI3K malignancies.
biotechpharmaceuticals
Company facts
- Founded
- 2016
- Employees
- 125
- Headquarters
- United States
- Type
- Public
- Listed
- NASDAQ: BBOT
freehire launches on Product Hunt on 26 August. Follow the page and you'll hear the moment it opens.
Follow →Developing small molecule therapeutics targeting RAS and PI3K malignancies.
Company facts